Home › Uterine Cancer › Rhode Island
Uterine Cancer clinical trials in Rhode Island
4 studies for Uterine Cancer are looking for participants at sites in Rhode Island.
Cities in Rhode Island
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Women & Infants Hospital of Rhode Island/The Program in Women´s Oncology - Clinic, Providence
- Women & Infants Hospital of Rhode Island, Providence
- Women & Infant´s Hospital Infusion Center, Providence
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT06952660Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Women and Infants Hospital of Rhode Island, Providence
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05579366DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Providence
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT06989112A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.